InChI=1S/C64H103N5O48/c1-17(77)65-33-22(82)6-61(57(97)98,113-49(33)38(87)26(86)10-70)110-28(12-72)40(89)50-34(66-18(2)78)23(83)7-62(114-50,58(99)100)111-29(13-73)41(90)51-35(67-19(3)79)24(84)8-63(115-51,59(101)102)112-30(14-74)42(91)52-36(68-20(4)80)25(85)9-64(116-52,60(103)104)117-53-46(95)56(108-47-31(15-75)105-54(96)45(94)44(47)93)107-32(16-76)48(53)109-55-37(69-21(5)81)43(92)39(88)27(11-71)106-55/h22-56,70-76,82-96H,6-16H2,1-5H3,(H,65,77)(H,66,78)(H,67,79)(H,68,80)(H,69,81)(H,97,98)(H,99,100)(H,101,102)(H,103,104)/t22-,23-,24-,25-,26+,27+,28+,29+,30+,31+,32+,33+,34+,35+,36+,37+,38+,39-,40+,41+,42+,43+,44+,45+,46+,47+,48-,49+,50+,51+,52+,53+,54+,55-,56-,61+,62+,63+,64-/m0/s1 |
BAILJZJFDJQIOQ-QOMVUZQYSA-N |
[H][C@]1(O[C@@](C[C@H](O)[C@H]1NC(C)=O)(O[C@H](CO)[C@@H](O)[C@]1([H])O[C@@](C[C@H](O)[C@H]1NC(C)=O)(O[C@H](CO)[C@@H](O)[C@]1([H])O[C@@](C[C@H](O)[C@H]1NC(C)=O)(O[C@H](CO)[C@@H](O)[C@]1([H])O[C@@](C[C@H](O)[C@H]1NC(C)=O)(O[C@@H]1[C@@H](O)[C@@H](O[C@H](CO)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1NC(C)=O)O[C@H]1[C@H](O)[C@@H](O)[C@H](O)O[C@@H]1CO)C(O)=O)C(O)=O)C(O)=O)C(O)=O)[C@H](O)[C@H](O)CO |
|
epitope
The biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds.
(via alpha-Neup5Ac-(2->8)-alpha-Neup5Ac-(2->8)-alpha-Neup5Ac-(2->8)-alpha-Neup5Ac-(2->3)-[beta-D-GalpNAc-(1->4)]-beta-D-Galp-(1->4)-beta-D-Glcp )
|
|
View more via ChEBI Ontology
Outgoing
|
α-Neup5Ac-(2→8)-α-Neup5Ac-(2→8)-α-Neup5Ac-(2→8)-α-Neup5Ac-(2→3)-[β-D-GalpNAc-(1→4)]-β-D-Galp-(1→4)-β-D-Glcp
(CHEBI:72621)
has role
epitope
(CHEBI:53000)
α-Neup5Ac-(2→8)-α-Neup5Ac-(2→8)-α-Neup5Ac-(2→8)-α-Neup5Ac-(2→3)-[β-D-GalpNAc-(1→4)]-β-D-Galp-(1→4)-β-D-Glcp
(CHEBI:72621)
is a
amino heptasaccharide
(CHEBI:70970)
α-Neup5Ac-(2→8)-α-Neup5Ac-(2→8)-α-Neup5Ac-(2→8)-α-Neup5Ac-(2→3)-[β-D-GalpNAc-(1→4)]-β-D-Galp-(1→4)-β-D-Glcp
(CHEBI:72621)
is a
galactosamine oligosaccharide
(CHEBI:22484)
|
|
5-acetamido-3,5-dideoxy-D-glycero-α-D-galacto-non-2-ulopyranonosyl-(2→8)-5-acetamido-3,5-dideoxy-D-glycero-α-D-galacto-non-2-ulopyranonosyl-(2→8)-5-acetamido-3,5-dideoxy-D-glycero-α-D-galacto-non-2-ulopyranonosyl-(2→8)-5-acetamido-3,5-dideoxy-D-glycero-α-D-galacto-non-2-ulopyranosonyl-(2→3)-[2-acetamido-2-deoxy-β-D-galactopyranosyl-(1→4)]-β-D-galactopyranosyl-(1→4)-β-D-glucopyranose
|
α-Neu5Ac-(2→8)-α-Neu5Ac-(2→8)-α-Neu5Ac-(2→8)-α-Neu5Ac-(2→3)-[β-D-GalNAc-(1→4)]-β-D-Gal-(1→4)-β-D-Glc
|
ChEBI
|
GalNAcb1-4(Neu5Aca2-8Neu5Aca2-8Neu5Aca2-8Neu5Aca2-3)Galb1-4Glcb
|
ChEBI
|
N-acetyl-α-neuraminyl-(2→8)-N-acetyl-α-neuraminyl-(2→8)-N-acetyl-α-neuraminyl-(2→8)-N-acetyl-α-neuraminyl-(2→3)-[N-acetyl-β-D-galactosaminyl-(1→4)]-β-D-galactosyl-(1→4)-β-D-glucose
|
ChEBI
|
NeuAcα2-8NeuAcα2-8NeuAcα2-8NeuAcα2-3(GalNAcβ1-4)Galβ1-4Glcβ
|
ChEBI
|
O-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl-(1→4)-O-[O-5-(acetylamino)-3,5-dideoxy-D-glycero-α-D-galacto-2-nonulopyranonosyl-(2→8)-O-5-(acetylamino)-3,5-dideoxy-D-glycero-α-D-galacto-2-nonulopyranonosyl-(2→8)-O-5-(acetylamino)-3,5-dideoxy-D-glycero-α-D-galacto-2-nonulopyranonosyl-(2→8)-5-(acetylamino)-3,5-dideoxy-D-glycero-α-D-galacto-2-nonulopyranonosyl-(2→3)]-O-β-D-galactopyranosyl-(1→4)-β-D-glucopyranose
|
ChEBI
|
19443021
|
PubMed citation
|
Europe PMC
|
25568069
|
PubMed citation
|
Europe PMC
|
31537530
|
PubMed citation
|
Europe PMC
|
|